LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

ADPKD, COVID-19, and Apixaban: The Treacherous Intracystic Bleeding − A Letter on Apixaban Causing Hepatic Cystic Bleeding by Shehi et al.

Photo by lamoune from unsplash

Shehi et al. [1] report on a 69-year-old Hispanic man who presented to the hospital with complaints of right upper quadrant pain for the past 3 days without any history… Click to show full abstract

Shehi et al. [1] report on a 69-year-old Hispanic man who presented to the hospital with complaints of right upper quadrant pain for the past 3 days without any history of trauma to the abdomen. Multiple renal and liver cysts were incidentally diagnosed 2 years previously during a routine ultrasound in the patient’s medical history. The patient was on oral apixaban because of COVID-19 pneumonia, elevated D-dimer levels, and a high risk of thromboembolic events. The patient received intravenous fluids, and blood transfusion and apixaban were stopped. Then, the patient underwent laparoscopic deroofing and partial resection of the liver, including a large cyst with adhesions to the abdominal wall. Histopathology discovered a fibrotic cyst wall with hemosiderin deposition and features of fibro-polycystic liver disease. After surgery, he recovered and was successfully discharged home [1].

Keywords: adpkd covid; apixaban; covid apixaban; treacherous intracystic; apixaban treacherous; bleeding

Journal Title: Case Reports in Gastroenterology
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.